2015
DOI: 10.1016/j.cgh.2014.06.023
|View full text |Cite
|
Sign up to set email alerts
|

Recurrence and Mortality Among Patients Hospitalized for Acute Lower Gastrointestinal Bleeding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
75
6
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 82 publications
(97 citation statements)
references
References 31 publications
9
75
6
3
Order By: Relevance
“…Prior studies indicated that non-aspirin antiplatelet use were risk factors for LGIB and its recurrence 8,10 , suggesting the initial assessment of non-aspirin antiplatelet agents as well as aspirin might become more important. We also found that no diarrhea and no symptoms of abdominal tenderness were significant predictors for severe bleeding.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…Prior studies indicated that non-aspirin antiplatelet use were risk factors for LGIB and its recurrence 8,10 , suggesting the initial assessment of non-aspirin antiplatelet agents as well as aspirin might become more important. We also found that no diarrhea and no symptoms of abdominal tenderness were significant predictors for severe bleeding.…”
Section: Discussionmentioning
confidence: 98%
“…Table 3 shows rates of severe bleeding, sensitivity, specificity, and likelihood ratios determined by predictive scores. The rates of severe bleeding with 0, 1, 2, 3, 4, and ≥ 5 predictors were 2.0%, 10.0%, 18.3%, 34.8%, 51.6%, and 75.7%, respectively (P < 0.001 for trend). The AUC of the score was 0.77 (95% CI, 0.73-0.82; Figure 2).…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 91%
See 1 more Smart Citation
“…The GI tract represents the most common bleeding site, with an age-standardized incidence rate of 5.8 per 1000 person-year [17], i.e., an approximately three-fold increased risk as compared with the general population [18]. The proportions of acute GI bleeders who take VKAs are 8-15% and 7% for upper [19][20][21] and lower GI bleeding, respectively [22]. The spectrum of endoscopic findings in VKA users who present with non-variceal acute upper GI bleeding is similar to that observed in patients taking no anticoagulants, with peptic ulcer being the main cause of bleeding [23].…”
Section: Introductionmentioning
confidence: 99%
“…1 Some patients still develop re-bleeding, or it may not be possible to stop hemodynamically significant bleeding by endoscopy. 15,16 In these cases there has been a paradigm shift from surgical treatment to interventional radiology in the last few years. 17 …”
Section: Endoscopic Therapymentioning
confidence: 99%